COMMD1 and lymphoma: In Kaplan-Meier analyses, the patients with high COMMD1 expression had a significantly worse PFS and a trend towards adverse lymphoma associated OS in comparison to the remaining patients with lower COMMD1 expression (5-year PFS 47% vs. 79%, p = 0.005 (Figure 4C) and 5-year OS 75% vs. 90%, p = 0.081).